JP2022550120A5 - - Google Patents
Info
- Publication number
- JP2022550120A5 JP2022550120A5 JP2022519423A JP2022519423A JP2022550120A5 JP 2022550120 A5 JP2022550120 A5 JP 2022550120A5 JP 2022519423 A JP2022519423 A JP 2022519423A JP 2022519423 A JP2022519423 A JP 2022519423A JP 2022550120 A5 JP2022550120 A5 JP 2022550120A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- molecule according
- met
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0119148 | 2019-09-26 | ||
| KR1020190119148A KR102685211B1 (ko) | 2019-09-26 | 2019-09-26 | 항-c-Met 항체 또는 그의 항원 결합 단편을 포함하는 키메라 항원 수용체, 및 이의 용도 |
| PCT/KR2020/013127 WO2021060932A1 (ko) | 2019-09-26 | 2020-09-25 | 항-c-met 항체 또는 그의 항원 결합 단편을 포함하는 키메라 항원 수용체, 및 이의 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550120A JP2022550120A (ja) | 2022-11-30 |
| JP2022550120A5 true JP2022550120A5 (https=) | 2023-09-22 |
| JP7373242B2 JP7373242B2 (ja) | 2023-11-02 |
Family
ID=75164878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519423A Active JP7373242B2 (ja) | 2019-09-26 | 2020-09-25 | 抗ｃ－ｍｅｔ抗体又はその抗原結合断片を含むキメラ抗原受容体、及びその用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12570719B2 (https=) |
| EP (1) | EP4039703A4 (https=) |
| JP (1) | JP7373242B2 (https=) |
| KR (1) | KR102685211B1 (https=) |
| CN (1) | CN114450407A (https=) |
| WO (1) | WO2021060932A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| KR20000006334A (ko) | 1998-06-26 | 2000-01-25 | 이선경 | 바이러스코딩염기서열이전혀없는고효율레트로바이러스벡터 |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| KR102042174B1 (ko) * | 2013-03-29 | 2019-11-08 | 삼성전자주식회사 | 인간화 및 친화도 성숙된 항 ｃ-Ｍｅｔ 항체 및 그의 용도 |
| KR101615619B1 (ko) | 2014-08-07 | 2016-04-26 | 주식회사 파멥신 | c-Met 특이적 인간 항체 및 그 제조방법 |
| CN109153975A (zh) * | 2015-12-28 | 2019-01-04 | 诺华股份有限公司 | 制备嵌合抗原受体表达细胞的方法 |
| KR102476846B1 (ko) * | 2016-02-05 | 2022-12-12 | 주식회사 헬릭스미스 | 항―ｃ―ＭＥＴ 항체 및 이의 용도 |
| CN106008721B (zh) * | 2016-08-09 | 2020-02-07 | 安徽未名细胞治疗有限公司 | 一种c-Met特异性嵌合抗原受体及其应用 |
| US20180257300A1 (en) | 2017-03-09 | 2018-09-13 | Applied Materials, Inc. | Additive manufacturing with energy delivery system having rotating polygon and adjustment of angle of light path |
| CN109422815A (zh) | 2017-08-28 | 2019-03-05 | 复旦大学 | 双特异性嵌合抗原受体c-Met/PD-1 scFv-CAR-T及其构建方法和应用 |
| CN108341881B (zh) | 2018-01-31 | 2020-08-18 | 深圳市默赛尔生物医学科技发展有限公司 | 带安全开关的嵌合抗原受体及其表达基因、其修饰的nk细胞及应用 |
| CN108707198A (zh) | 2018-06-28 | 2018-10-26 | 李永海 | 识别人c-Met蛋白的人源单链抗体、诊断试剂及其CAR-T细胞制剂 |
| KR102353568B1 (ko) | 2018-11-14 | 2022-01-20 | 주식회사 헬릭스미스 | 안정성이 향상된 항 c-Met 항체 또는 그의 항원 결합 단편 |
| KR102077987B1 (ko) * | 2018-12-19 | 2020-02-17 | 주식회사 헬릭스미스 | 신장 질환 진단용 바이오 마커 |
| US11866493B2 (en) | 2019-11-01 | 2024-01-09 | East Tennessee State University Research Foundation | Single-chain variable fragment of Met monoclonal antibody and methods of use in CAR T cell therapy |
-
2019
- 2019-09-26 KR KR1020190119148A patent/KR102685211B1/ko active Active
-
2020
- 2020-09-25 JP JP2022519423A patent/JP7373242B2/ja active Active
- 2020-09-25 EP EP20868836.6A patent/EP4039703A4/en active Pending
- 2020-09-25 US US17/763,712 patent/US12570719B2/en active Active
- 2020-09-25 CN CN202080067658.8A patent/CN114450407A/zh active Pending
- 2020-09-25 WO PCT/KR2020/013127 patent/WO2021060932A1/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113185616B (zh) | 靶向bcma的嵌合抗原受体及其使用方法 | |
| KR102512934B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이들의 이용 방법 | |
| JP2025028239A5 (https=) | ||
| JP7269167B2 (ja) | モジュラー四価二重特異性抗体プラットフォーム | |
| US20210177951A1 (en) | Engineered cells & methods | |
| CA3032581A1 (en) | Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule | |
| JP2024532485A5 (https=) | ||
| IL298326A (en) | Anti-her2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same | |
| TW201904997A (zh) | 引導及導航控制蛋白質以及彼之製造及使用方法 | |
| EP3523331A1 (en) | Chimeric antigen receptors for the treatment of cancer | |
| CN114127113A (zh) | 与钙网蛋白结合的多功能分子及其用途 | |
| JP2017500869A5 (https=) | ||
| WO2022222910A1 (zh) | 靶向gprc5d的抗体及其用途 | |
| WO2022105826A1 (zh) | 靶向nkg2a的抗体及其用途 | |
| WO2022152168A1 (zh) | 靶向ror1的抗体及其用途 | |
| CN121779568A (zh) | 与t细胞结合的多功能分子及其治疗自身免疫性病症的用途 | |
| JP2022513372A5 (https=) | ||
| JP2024522069A (ja) | Ｉｌ－２１ポリペプチド及び標的化コンストラクト | |
| US20240317815A1 (en) | T-cell modulatory multimeric polypeptides and methods of use thereof | |
| CN113891718A (zh) | 人工免疫监视嵌合抗原受体(ai-car)及其表达细胞 | |
| JP6995145B2 (ja) | Ｈｌａ拘束性にｈｌａ－ａ２／ｔｙｒｄに結合することができる抗体及びその用途 | |
| WO2023202280A1 (zh) | 抗B7H6的scFv抗体、其编码基因及其应用 | |
| US20250101104A1 (en) | Bispecific molecule with tunable affinity to a targeted antigen | |
| TW202309294A (zh) | 病毒載體生產系統 | |
| US20250019411A1 (en) | T-Cell Engaging Polypeptides and Methods of Use Thereof |